Author: SleepWorld Magazine

睡眠裝置與設備

FDA Clears First Home Use Spirometer

Monitored Therapeutics, Inc. (MTI), an emerging best-in-class remote patient management company, has received FDA 510(k) clearance for its GoSpiro® Home Spirometer. This is the first spirometer that was specifically developed as a home-use wireless connected spirometer that works with a wide range of smartphones, tablets or PCs. Michael Taylor, Chief […]

研究與調查 產品與供應商最新動態

最新研究:飛利浦 Trilogy 系統顯示,支付方與醫院可透過降低慢性阻塞性肺病(COPD)患者的再入院成本及住院率,節省數百萬美元

多面向的治療方法在提升患者照護品質的同時,亦帶來顯著的財務效益 飛利浦(Royal Philips)公佈了一項最新研究結果(1),顯示嚴重慢性阻塞性肺病(COPD)(2) 患者的住院費用、支付方成本及住院率均顯著下降。這項名為「透過減少住院次數所節省的成本 […]」的研究

睡眠裝置與設備

ResMed Unveils AirMini – the World’s Smallest CPAP

Sleek product design and engaging smartphone app revolutionizes CPAP experience for the world’s 100 million sleep apnea sufferers ResMed  today unveiled its AirMini™, the world’s smallest CPAP machine – a game-changer for people with sleep apnea. Achieving new heights in patient-centered innovation, AirMini packs ResMed’s clinically proven CPAP technology along […]

睡眠裝置與設備

Philips Simplifies Travel for Sleep Apnea Patients with New Compact and Connected DreamStation Go

Advanced CPAP offers same clinically-proven therapy as Philips’ award-winning DreamStation at half the size for reliable, uninterrupted therapy while on-the-go Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced the launch of DreamStation Go, its newest and smallest positive airway pressure (PAP) device designed to simplify travel […]

產品與供應商最新動態

ResMed 贊助的一項新研究顯示,對於未經治療的中樞性睡眠呼吸中止症患者,有一種極具前景的治療方案

ResMed Inc. 今日宣布,根據迄今為止針對治療後出現中樞性睡眠呼吸中止症(CSA)患者所進行的最大規模分析顯示,患有阻塞性睡眠呼吸中止症且後續發展為中樞性睡眠呼吸中止症(CSA)的患者,在從持續氣道正壓通氣(CPAP)療法轉為適應性伺服通氣(ASV)療法後,治療依從性更高。該研究分析了匿名、[…]

呼吸系統

Sunovion Announces Utibron™ Neohaler® Inhalation Powder Now Available in US

UTIBRON NEOHALER is a new combination therapy for people with chronic obstructive pulmonary disease (COPD) that addresses unmet patient needs Sunovion Pharmaceuticals Inc today announced that Utibron™Neohaler® (indacaterol/glycopyrrolate) inhalation powder is now available at pharmacies in the United States for the long-term maintenance treatment of airflow obstruction in people with chronic […]